Kymera Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of KYMR for the last quarter is 47.88 M USD, and it's 912.80% higher compared to the previous quarter. The net income of Q4 23 is -14.37 M USD.